Tradestie Institutional Equity Comparison Engine

REGN vs AMGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMGN Overall Edge

AMGN Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amgen Inc (AMGN) driven by superior Growth & Margin, Momentum & Technical while REGN counters with relative strength in Valuation, Options & Structure. Fundamentally, REGN trades at 14.9x Forward P/E with 30.4% operating margin (+36.3% YoY revenue) versus AMGN at 17.5x Forward P/E and 34.1% operating margin (+8.5% YoY). In options structure, REGN sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against AMGN sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner REGN
REGN 14.9x vs AMGN 17.5x Fwd P/E
Growth & Margin Winner AMGN
Op Margin 30.4% vs 34.1% ยท YoY +36.3% vs +8.5%
Momentum & Technical Winner AMGN
1Y +27.3% vs +27.6% ยท 52W Pos 83% vs 74%
Options & Structure Winner REGN
CONSOLIDATION (6th %ile IV) vs CONSOLIDATION (6th %ile IV)
REGN NASDAQ
Regeneron Pharmaceuticals Inc
Pharmaceutical Preparations
$923.34
-2.35% 1D
Market Cap $97.8B
1M Return +14.61%
1Y Return +27.3%
Forward P/E 14.9x
Unified AI Score
42.6 / 100 HOLD
Tech 19.0 Fund 45.0 Flow 68.0 Mom 56.0
AMGN NASDAQ
Amgen Inc
Biological Products, (No Disgnostic Substances)
$438.82
-1.14% 1D
Market Cap $240.1B
1M Return +0.11%
1Y Return +27.57%
Forward P/E 17.5x
Unified AI Score
48.4 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 68.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: REGN +27.3% AMGN +27.57% Spread: +0.27 pp (AMGN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period REGN Revenue AMGN Revenue REGN Op. Margin AMGN Op. Margin Margin Edge
FY2018 $5.15B $23.8B 49.3% 43.2% REGN
FY2019 $6.56B $23.4B 33.7% 41.4% AMGN
FY2020 $8.50B $25.4B 42.1% 35.9% REGN
FY2021 $16.1B $26.0B 55.7% 29.4% REGN
FY2022 $12.2B $26.3B 38.9% 36.3% REGN
FY2023 $13.1B $28.2B 30.9% 28.0% REGN
FY2024 $14.2B $33.4B 28.1% 21.7% REGN
FY2025 $14.3B $36.8B 24.9% 24.7% REGN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: REGN (5) vs AMGN (5)
Institutional Metric REGN AMGN Criterion Row Winner
Market Capitalization Scale $97.8B $240.1B Larger Scale AMGN
Trailing P/E Ratio Valuation 20.9x 25.7x Lower Multiple REGN
Forward P/E Ratio Valuation 14.9x 17.5x Lower Multiple REGN
Revenue Growth (YoY) Growth +36.3% +8.5% Higher Growth REGN
Operating Margin (TTM) Profitability 30.4% 34.1% Higher Margin AMGN
Net Profit Margin Profitability 28.5% 24.1% Higher Margin REGN
Return on Equity (ROE) Capital Efficiency 14.9% 78.3% Higher ROE AMGN
52-Week Range Position Momentum 83% ($592โ€“$992) 74% ($312โ€“$484) Stronger Trend REGN
Beta / 30D Volatility Risk Regime 0.32ฮฒ ยท 55% Vol 0.47ฮฒ ยท 26% Vol Lower Realized Risk AMGN
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite AMGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full REGN vs AMGN Buy Guide
REGN CONSOLIDATION
55d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live REGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AMGN CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live AMGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither REGN nor AMGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.